[ad_1]
Synopsis
Contributing over 40% to whole revenues, home market gross sales grew 16% on a excessive base of Covid-led drug gross sales. Sustained progress within the firm’s core therapies reminiscent of respiratory and urology compensated for the normalising contribution of the Covid portfolio.
ET Intelligence Group: Cipla posted higher-than-expected revenue progress at 7% within the September quarter, aided by a ten% enhance in revenues.
Contributing over 40% to whole revenues, home market gross sales grew 16% on a excessive base of Covid-led drug gross sales. Sustained progress within the firm’s core therapies reminiscent of respiratory and urology compensated for the normalising contribution of the Covid portfolio.
The contribution of the Covid portfolio –
- FONT SIZE
AbcSmall
AbcMedium
AbcGiant
Register to learn the complete article
You’ve bought this Prime Story as a Free Reward
₹399/month
Month-to-month
PLAN
Billed Quantity ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Quantity ₹2,499
15
Days Trial
+Contains DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Yr
PLAN
Billed Quantity ₹3,599
15
Days Trial
+Contains DocuBay and TimesPrime Membership.
Already a Member? Signal In now
Get Supply
Why ?
-
Unique Financial Instances Tales, Editorials & Skilled opinion throughout 20+ sectors
-
Inventory evaluation. Market Analysis. Business Developments on 4000+ Shares
-
Clear expertise with
Minimal Adverts -
Remark & Interact with ET Prime neighborhood -
Unique invitations to Digital Occasions with Business Leaders -
A trusted group of Journalists & Analysts who can finest filter sign from noise
[ad_2]
Source link